Literature DB >> 4133584

In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro.

D Ilfeld, C Carnaud, I R Cohen, N Trainin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4133584     DOI: 10.1002/ijc.2910120122

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

1.  Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro.

Authors:  M A Kall; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Hydantoin immunosuppression and carcinogenesis.

Authors:  Y Levo; O Markowitz; N Trainin
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

3.  Increased reactivity of mouse spleen cells sensitized in vitro against syngeneic tumor cells in the presence of a thymic humoral factor.

Authors:  C Carnaud; D Ilfeld; I Brook; N Trainin
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

4.  Enhancing and inhibiting effects of spleen cells from tumour-bearing mice on growth of virus-induced primary sarcoma.

Authors:  H Kimura; T Aoki
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

5.  Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice.

Authors:  A Gabizon; N Trainin
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

6.  In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.

Authors:  R C Burton; N L Warner
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

7.  Increased incidence of urethane induced lung adenomata by autosensitized lymphocytes.

Authors:  Y Levo; C Carnaud; I R Cohen; N Trainin
Journal:  Br J Cancer       Date:  1974-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.